title: Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.
abstract: Lymphomas represent a wide group of heterogenic diseases with different biological and clinical behavior. The underlying microenvironment-specific composition seems to play an essential role in this scenario, harboring the ability to develop successful immune responses or, on the contrary, leading to immune evasion and even promotion of tumor growth. Depending on surrounding lymphoid infiltrates, lymphomas may have different prognosis. Moreover, recent evidences have emerged that confer a significant impact of main lymphoma's treatment over microenvironment, with clinical consequences. In this review, we summarize these concepts from a pathological and clinical perspective. Also, the state of the art of lymphoma's anti-idiotype vaccine development is revised, highlighting the situations where this strategy has proven to be successful and eventual clues to obtain better results in the future.
authors.affiliation: Pathology Department, Hospital de Tortosa Verge de la Cinta, 41300 Tortosa, Spain.
authors.forename: Tomás
authors.initials: T
authors.lastname: Alvaro
authors.forename: Luis
authors.initials: L
authors.lastname: de la Cruz-Merino
authors.forename: Fernando
authors.initials: F
authors.lastname: Henao-Carrasco
authors.forename: José Luis
authors.initials: JL
authors.lastname: Villar Rodríguez
authors.forename: David
authors.initials: D
authors.lastname: Vicente Baz
authors.forename: Manuel
authors.initials: M
authors.lastname: Codes Manuel de Villena
authors.forename: Mariano
authors.initials: M
authors.lastname: Provencio
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology*; D059016:Tumor Microenvironment
chemical_list: D000970:Antineoplastic Agents
references.citation: Eur J Haematol Suppl. 2007 Jan;(67):5-14
references.pmid: 17206982
references.citation: Clin Cancer Res. 2008 Feb 1;14(3):685-91
references.pmid: 18245527
references.citation: Hematology Am Soc Hematol Educ Program. 2007;:243-9
references.pmid: 18024636
references.citation: J Clin Invest. 2006 Oct;116(10):2777-90
references.pmid: 17016559
references.citation: Nature. 2000 Apr 27;404(6781):999-1003
references.pmid: 10801129
references.citation: Blood. 2006 Jan 15;107(2):628-36
references.pmid: 16179369
references.citation: Br J Cancer. 2006 Jan 30;94(2):259-67
references.pmid: 16404427
references.citation: FASEB J. 2004 Nov;18(14):1716-8
references.pmid: 15345697
references.citation: Lancet Oncol. 2009 Jul;10(7):718-26
references.pmid: 19573801
references.citation: Blood. 2002 Feb 1;99(3):1038-43
references.pmid: 11807010
references.citation: Nat Med. 2007 Jan;13(1):54-61
references.pmid: 17187072
references.citation: Oncogene. 2003 Nov 24;22(53):8543-67
references.pmid: 14634618
references.citation: Oncologist. 1999;4(2):106-11
references.pmid: 10337380
references.citation: N Engl J Med. 2006 Jun 8;354(23):2503-4
references.pmid: 16760453
references.citation: Nat Med. 2000 Apr;6(4):443-6
references.pmid: 10742152
references.citation: J Immunol. 1987 Feb 15;138(4):1289-96
references.pmid: 3492546
references.citation: Oncologist. 2008 Dec;13(12):1246-54
references.pmid: 19056856
references.citation: J Clin Oncol. 2007 Apr 1;25(10):1289-91; author reply 1291-2
references.pmid: 17401023
references.citation: J Clin Oncol. 2002 Jun 15;20(12):2904-5; author reply 2905
references.pmid: 12065568
references.citation: Leukemia. 2008 Jan;22(1):49-58
references.pmid: 17914412
references.citation: Annu Rev Pathol. 2006;1:119-50
references.pmid: 18039110
references.citation: Science. 2003 Feb 14;299(5609):1057-61
references.pmid: 12522256
references.citation: Am J Clin Pathol. 1988 Sep;90(3):257-61
references.pmid: 2970792
references.citation: Blood. 2005 Jul 1;106(1):338-44
references.pmid: 15769894
references.citation: Nat Rev Cancer. 2009 Sep;9(9):675-81
references.pmid: 19701243
references.citation: J Clin Oncol. 2009 Jan 1;27(1):154-5
references.pmid: 19029411
references.citation: Clin Cancer Res. 2010 Jan 15;16(2):637-50
references.pmid: 20068089
references.citation: Ann Hematol. 2005 Oct;84(10):661-6
references.pmid: 15875183
references.citation: J Clin Oncol. 2000 Apr;18(8):1614-21
references.pmid: 10764421
references.citation: Blood. 2003 Feb 15;101(4):1220-35
references.pmid: 12393483
references.citation: J Immunother. 2007 Jan;30(1):64-74
references.pmid: 17198084
references.citation: Expert Rev Vaccines. 2006 Jun;5(3):381-94
references.pmid: 16827622
references.citation: J Clin Invest. 2004 May;113(10):1498-510
references.pmid: 15146248
references.citation: Mutat Res. 2006 May 11;597(1-2):119-32
references.pmid: 16438994
references.citation: Clin Cancer Res. 2009 Nov 1;15(21):6582-94
references.pmid: 19861448
references.citation: Clin Cancer Res. 2007 Jul 1;13(13):3776-82
references.pmid: 17606707
references.citation: N Engl J Med. 2004 Nov 18;351(21):2159-69
references.pmid: 15548776
references.citation: Haematologica. 2008 Feb;93(2):193-200
references.pmid: 18223287
references.citation: Blood. 2005 Mar 1;105(5):1851-61
references.pmid: 15550490
references.citation: Haematologica. 2006 Dec;91(12):1605-12
references.pmid: 17145596
references.citation: Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10972-7
references.pmid: 8855293
references.citation: Immunol Rev. 2007 Dec;220:47-59
references.pmid: 17979839
references.citation: Blood. 2008 Sep 1;112(5):1557-69
references.pmid: 18725574
references.citation: J Clin Oncol. 2006 Dec 1;24(34):5350-7
references.pmid: 17135637
references.citation: Blood. 2002 Feb 15;99(4):1314-9
references.pmid: 11830481
references.citation: Curr Opin Immunol. 2008 Oct;20(5):545-57
references.pmid: 18573339
references.citation: Cell. 2006 Jan 27;124(2):263-6
references.pmid: 16439202
references.citation: J Clin Oncol. 2008 Jun 1;26(16):2725-31
references.pmid: 18427151
references.citation: N Engl J Med. 2000 Jul 6;343(1):37-49
references.pmid: 10882768
references.citation: N Engl J Med. 2008 Nov 27;359(22):2313-23
references.pmid: 19038878
references.citation: J Leukoc Biol. 1999 Aug;66(2):345-9
references.pmid: 10449179
references.citation: Blood. 1999 Apr 15;93(8):2688-96
references.pmid: 10194449
references.citation: Oncologist. 2007;12 Suppl 2:22-6
references.pmid: 18039636
references.citation: Leukemia. 2004 Mar;18(3):589-96
references.pmid: 14712286
references.citation: J Clin Oncol. 2003 Jun 15;21(12):2415-32
references.pmid: 12805342
references.citation: Br J Haematol. 2009 May;145(4):468-80
references.pmid: 19344401
references.citation: Anticancer Drugs. 2002 Nov;13 Suppl 2:S3-10
references.pmid: 12710585
references.citation: Haematologica. 2009 Jan;94(1):70-7
references.pmid: 19059937
references.citation: J Immunol. 1990 Apr 1;144(7):2550-7
references.pmid: 1969451
references.citation: Ann Oncol. 2009 Oct;20(10):1688-96
references.pmid: 19542249
references.citation: Nat Rev Cancer. 2005 May;5(5):397-405
references.pmid: 15864281
references.citation: Nature. 2005 Dec 8;438(7069):820-7
references.pmid: 16341007
references.citation: N Engl J Med. 2001 Apr 5;344(14):1058-66
references.pmid: 11287977
references.citation: Ann Oncol. 1998;9 Suppl 5:S21-4
references.pmid: 9926233
references.citation: Cancer Immunol Immunother. 2007 Nov;56(11):1687-700
references.pmid: 17571260
references.citation: Ann Hematol. 2005 Aug;84(8):510-6
references.pmid: 15834569
references.citation: Leuk Lymphoma. 2005 Nov;46(11):1581-91
references.pmid: 16236613
references.citation: J Clin Oncol. 2008 Nov 10;26(32):5156-64
references.pmid: 18854568
references.citation: Blood. 2004 Jun 1;103(11):4251-8
references.pmid: 14976040
references.citation: Proc Natl Acad Sci U S A. 1983 Jun;80(12):3816-20
references.pmid: 6602341
references.citation: J Clin Oncol. 2001 Feb 1;19(3):720-6
references.pmid: 11157023
references.citation: Cell. 1995 Apr 7;81(1):9-12
references.pmid: 7536631
references.citation: Haematologica. 2003 Sep;88(9):1002-12
references.pmid: 12969808
references.citation: Cancer Res. 2008 Jan 15;68(2):450-6
references.pmid: 18199539
references.citation: Science. 2004 May 14;304(5673):1014-8
references.pmid: 15143282
references.citation: J Clin Pathol. 2003 Jun;56(6):423-5
references.pmid: 12783967
references.citation: Nature. 2005 Aug 25;436(7054):1186-90
references.pmid: 15995699
references.citation: Crit Rev Oncol Hematol. 2009 May;70(2):103-13
references.pmid: 18996025
references.citation: Trends Immunol. 2002 Nov;23(11):549-55
references.pmid: 12401408
references.citation: J Immunol. 2007 Jun 1;178(11):6840-8
references.pmid: 17513732
references.citation: Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5866-73
references.pmid: 14676108
references.citation: Cancer Immunol Immunother. 2001 Dec;50(10):566-8
references.pmid: 11776379
references.citation: Cancer Res. 2003 Aug 1;63(15):4516-20
references.pmid: 12907625
references.citation: Cancer Control. 2000 Nov-Dec;7(6):513-22
references.pmid: 11088060
references.citation: Nat Med. 2007 Sep;13(9):1050-9
references.pmid: 17704786
references.citation: Blood. 2007 Jun 1;109(11):4952-63
references.pmid: 17284527
references.citation: Curr Opin Immunol. 2008 Oct;20(5):504-11
references.pmid: 18573340
references.citation: Blood. 2006 Nov 1;108(9):2957-64
references.pmid: 16825494
references.citation: Nat Med. 2005 Sep;11(9):986-91
references.pmid: 16116429
references.citation: Blood. 2002 Jun 15;99(12):4283-97
references.pmid: 12036854
references.citation: J Transl Med. 2005 Feb 08;3(1):8
references.pmid: 15698481
references.citation: Br J Cancer. 2002 Jul 1;87(1):21-7
references.pmid: 12085250
references.citation: J Cell Biochem. 2007 Jul 1;101(4):805-15
references.pmid: 17226777
references.citation: J Exp Med. 2010 Mar 15;207(3):637-50
references.pmid: 20156971
references.citation: Blood. 2009 Oct 15;114(16):3367-75
references.pmid: 19636060
references.citation: Blood. 2009 Oct 1;114(14):2936-44
references.pmid: 19671921
references.citation: Clin Cancer Res. 2005 Feb 15;11(4):1467-73
references.pmid: 15746048
references.citation: Crit Rev Oncol Hematol. 2009 Mar;69(3):187-98
references.pmid: 18675551
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Apoptosis. 2006 Jun;11(6):1013-23
references.pmid: 16544097
references.citation: Haematologica. 2009 Jan;94(1):16-21
references.pmid: 19118376
references.citation: Cancer Sci. 2007 Sep;98(9):1368-72
references.pmid: 17640305
references.citation: Expert Opin Biol Ther. 2009 Jan;9(1):21-8
references.pmid: 19063690
references.citation: N Engl J Med. 1992 Oct 22;327(17):1209-15
references.pmid: 1406793
references.citation: Oncologist. 2008 Sep;13(9):954-66
references.pmid: 18779537
references.citation: Cancer Res. 2008 Oct 1;68(19):8122-6
references.pmid: 18829571
references.citation: Blood. 2005 Jan 1;105(1):301-7
references.pmid: 15345589
references.citation: Br Med Bull. 2002;62:149-62
references.pmid: 12176857
references.citation: J Immunol. 2008 Sep 1;181(5):3099-107
references.pmid: 18713980
references.citation: Expert Rev Vaccines. 2009 Jan;8(1):43-50
references.pmid: 19093772
references.citation: Semin Cancer Biol. 2006 Feb;16(1):38-52
references.pmid: 16139507
references.citation: Cancer Res. 2004 Mar 15;64(6):2205-11
references.pmid: 15026364
references.citation: J Clin Invest. 2007 May;117(5):1167-74
references.pmid: 17476346
references.citation: Cell Death Differ. 2007 Jul;14(7):1237-43
references.pmid: 17431418
references.citation: Blood. 2004 Mar 1;103(5):1755-62
references.pmid: 14604957
references.citation: Blood. 2005 Sep 15;106(6):2169-74
references.pmid: 15933054
references.citation: Leukemia. 2001 Mar;15(3):458-64
references.pmid: 11237071
references.citation: J Natl Cancer Inst. 2006 Sep 20;98(18):1292-301
references.pmid: 16985248
references.citation: Cell Death Differ. 2007 Oct;14(10):1848-50
references.pmid: 17657249
references.citation: J Clin Oncol. 2009 Jun 20;27(18):3036-43
references.pmid: 19414675
references.citation: Cancer Immunol Immunother. 2004 Feb;53(2):73-8
references.pmid: 14610619
references.citation: J Clin Oncol. 2005 Dec 10;23(35):8950-8
references.pmid: 16061910
references.citation: J Clin Invest. 2008 Jun;118(6):1991-2001
references.pmid: 18523649